ATE90096T1 - Arylsubstituierte naphthyridin- und pyridopyrazin-derivate. - Google Patents

Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.

Info

Publication number
ATE90096T1
ATE90096T1 AT87303102T AT87303102T ATE90096T1 AT E90096 T1 ATE90096 T1 AT E90096T1 AT 87303102 T AT87303102 T AT 87303102T AT 87303102 T AT87303102 T AT 87303102T AT E90096 T1 ATE90096 T1 AT E90096T1
Authority
AT
Austria
Prior art keywords
aryl
disclosed
substituted naphthyridine
pyridopyrazine derivatives
substituted
Prior art date
Application number
AT87303102T
Other languages
English (en)
Inventor
David John Blythin
Marvin Ira Siegel
Ho-Jane Shue
Sidney Randall Smith
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/921,288 external-priority patent/US4882332A/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE90096T1 publication Critical patent/ATE90096T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT87303102T 1986-04-11 1987-04-09 Arylsubstituierte naphthyridin- und pyridopyrazin-derivate. ATE90096T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85106886A 1986-04-11 1986-04-11
US06/921,288 US4882332A (en) 1986-10-20 1986-10-20 Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives
EP87303102A EP0241291B1 (de) 1986-04-11 1987-04-09 Arylsubstituierte Naphthyridin- und Pyridopyrazin-Derivate

Publications (1)

Publication Number Publication Date
ATE90096T1 true ATE90096T1 (de) 1993-06-15

Family

ID=27126973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87303102T ATE90096T1 (de) 1986-04-11 1987-04-09 Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.

Country Status (16)

Country Link
EP (1) EP0241291B1 (de)
JP (1) JPH0774215B2 (de)
KR (1) KR870010049A (de)
AT (1) ATE90096T1 (de)
AU (1) AU609389B2 (de)
CA (1) CA1324381C (de)
DE (1) DE3786036T2 (de)
DK (1) DK186487A (de)
ES (1) ES2054665T3 (de)
FI (1) FI88033C (de)
HU (1) HU200768B (de)
IL (1) IL82150A0 (de)
NO (1) NO165923C (de)
NZ (1) NZ219931A (de)
OA (1) OA08583A (de)
PT (1) PT84658B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
CA2745071C (en) * 2008-12-17 2018-08-28 Yufang Xiao C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
EP0144996B1 (de) * 1983-12-14 1990-02-28 Schering Corporation Substituierte Spiropyridinderivate, diese enthaltende pharmazeutische Zubereitungen, Verfahren zu ihrer Herstellung und Zubereitungen
US4596809A (en) * 1985-03-25 1986-06-24 Schering Corporation Substituted 1,8-naphthyridinones, useful as anti-allergic agents
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser

Also Published As

Publication number Publication date
IL82150A0 (en) 1987-10-30
HUT43847A (en) 1987-12-28
FI88033C (fi) 1993-03-25
NO871507L (no) 1987-10-12
AU7135887A (en) 1987-10-15
DK186487D0 (da) 1987-04-10
AU609389B2 (en) 1991-05-02
EP0241291A3 (en) 1989-05-31
NO165923B (no) 1991-01-21
HU200768B (en) 1990-08-28
EP0241291B1 (de) 1993-06-02
DE3786036T2 (de) 1993-09-09
ES2054665T3 (es) 1994-08-16
DE3786036D1 (de) 1993-07-08
FI871568A (fi) 1987-10-12
KR870010049A (ko) 1987-11-30
NO871507D0 (no) 1987-04-10
NO165923C (no) 1991-05-02
FI871568A0 (fi) 1987-04-09
EP0241291A2 (de) 1987-10-14
JPH0774215B2 (ja) 1995-08-09
CA1324381C (en) 1993-11-16
PT84658B (pt) 1989-11-30
FI88033B (fi) 1992-12-15
OA08583A (fr) 1988-09-30
DK186487A (da) 1987-10-12
JPS62270582A (ja) 1987-11-24
NZ219931A (en) 1989-10-27
PT84658A (en) 1987-05-01

Similar Documents

Publication Publication Date Title
DE3752007D1 (de) Mittel zur Entziehung von Endprodukten der fortgeschrittenen Glycosylation
NZ219138A (en) Opthalmic use of quinolone and naphthyridone antibiotics
DE3786036T2 (de) Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.
OA08480A (en) Polycylic quinoline, naphthyridine and pyrazinopyridine derivatives.
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE3887137D1 (de) Mittel zur prophylaxe und behandlung einer pankreatischen erkrannkung oder dergleichen.